VRXA
Veraxa Biotech AG - Ordinary Shares (VRXA)
$04
About Veraxa Biotech AG - Ordinary Shares (VRXA)
Veraxa Biotech Holding AG engages in operating an oncology-focused biotechnology company, which is the Veraxa Biotech AG (Company). The Company focuses on the development of novel antibody-based drug platforms for the treatment of cancer. The company was founded on June 25, 2025 and is headquartered in Zurich, Switzerland.
Details
Daily high
$1.06
Daily low
$1.03
Price at open
$1.03
52 Week High
$27.36
52 Week Low
$0.90
Market cap
154.4M
Dividend yield
-
Volume
111,526
Avg. volume
164,235
P/E ratio
4.88
Veraxa Biotech AG - Ordinary Shares News
Details
Daily high
$1.06
Daily low
$1.03
Price at open
$1.03
52 Week High
$27.36
52 Week Low
$0.90
Market cap
154.4M
Dividend yield
-
Volume
111,526
Avg. volume
164,235
P/E ratio
4.88